Clinical trials
Phase 3 Body Weight trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 5 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Par Pharmaceutical, Inc. | 2 |
| Pfizer | 2 |
| Alkermes, Inc. | 1 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| Ethicon Endo-Surgery | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Loma Linda University | 1 |
| Mark Vander Weg | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Body Weight | 18 |
| Obesity | 7 |
| Overweight | 5 |
| Anorexia | 3 |
| Cachexia | 3 |
| Diabetes Mellitus | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Endocrine System Diseases | 3 |
| Glucose Metabolism Disorders | 3 |
| Metabolic Diseases | 3 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.